Nasal vaccination has been identified as a factor that may totally change the vaccine industry.

Eurocine Vaccines AB is a company focusing on the development of patent protected nasal vaccines such as influenza, pneumonia and HIV.

Short interview with CEO Hans Arwidsson on Oct 15.